Background: It has been established that the genomic background of Mycobacterium tuberculosis may influence disease progression, in particular for the Beijing family and the Latin American and Mediterranean (LAM)/RD strains. The purpose of this study was to evaluate the prevalence of the LAM/RD genotype in cases of tuberculosis from Mexico and their drug susceptibility profile.
Methods: Two hundred eighteen M. tuberculosis isolates were screened by 43-spacer spoligotyping. The LAM/RD genotype was confirmed by multiplex PCR, and the drug susceptibility testing was carried out in solid Löwenstein-Jensen media.
Results: Among the LAM strains identified, 24 (63.1%) were confirmed as M. tuberculosis RD. All RD strains shared the RD174 deletion, that was associated with isoniazid resistance (p=0.0264).
Conclusions: We documented for the first time the isolation of the LAM/RD genotype in pulmonary cases of tuberculosis in Mexico, and we found resistance to the first-line anti-tuberculosis drug isoniazid in these strains.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eimce.2020.07.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!